Martin Boura

Martin Boura has a diverse work experience spanning over multiple roles in various companies. Martin began their career at R&D Systems as a Technical Correspondent from July 2007 to August 2008. Martin then moved on to Novartis as a Junior Product Manager for Certican, Transplantation from April 2009 to December 2009. Martin joined Roche next and served as a Sales Representative for Transplantation - Cellcept/Mircera from August 2010 to December 2011. Martin then transitioned into the role of Oncology Product Manager, first for Avastin Breast Cancer from December 2011 to June 2012, and then for Avastin Glioblastoma from June 2012 to April 2015. Martin then joined Sanofi Genzyme as a Rare Diseases Product Manager for MPS from April 2015 to May 2018, followed by the role of Marketing Manager for Rare Diseases from May 2018 to June 2021. Martin then joined Illumina as an EMEA Marketing Manager for Genetic Disease Testing from June 2021 to April 2022. Martin's most recent position is at Eisai EMEA where they worked as a Marketing Manager from April 2022 to August 2023. Currently, they hold the position of Associate Director of Operations for France at Rhythm Pharmaceuticals Inc. since August 2023.

Martin Boura completed a Master of Science degree in Biotechnology at the University of East London from 2005 to 2006. Martin also pursued a Specialized Master degree in Medical Management at ESCP Business School from 2008 to 2009.